Tan Kun, Zhang Zhenni, Miao Kai, Yu Yong, Sui Linlin, Tian Jianhui, An Lei
National Engineering Laboratory for Animal Breeding; Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture; College of Animal Science and Technology, China Agricultural University, No. 2 Yuanmingyuan West Road, Beijing 100193, P. R. China.
National Engineering Laboratory for Animal Breeding; Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture; College of Animal Science and Technology, China Agricultural University, No. 2 Yuanmingyuan West Road, Beijing 100193, P. R. China
Mol Hum Reprod. 2016 Jul;22(7):485-98. doi: 10.1093/molehr/gaw028. Epub 2016 Apr 18.
How does in vitro fertilization (IVF) alter promoter DNA methylation patterns and its subsequent effects on gene expression profiles during placentation in mice?
IVF-induced alterations in promoter DNA methylation might have functional consequences in a number of biological processes and functions during IVF placentation, including actin cytoskeleton organization, hematopoiesis, vasculogenesis, energy metabolism and nutrient transport.
During post-implantation embryonic development, both embryonic and extraembryonic tissues undergo de novo DNA methylation, thereby establishing a global DNA methylation pattern, and influencing gene expression profiles. Embryonic and placental tissues of IVF conceptuses can have aberrant morphology and functions, resulting in adverse pregnancy outcomes such as pregnancy loss, low birthweight, and long-term health effects. To date, the IVF-induced global profiling of DNA methylation alterations, and their functional consequences on aberrant gene expression profiles in IVF placentas have not been systematically studied.
STUDY DESIGN, SAMPLES/MATERIALS, METHODS: Institute for Cancer Research mice (6 week-old females and 8-9 week-old males) were used to generate in vivo fertilization (IVO) and IVF blastocysts. After either IVO and development (IVO group as control) or in vitro fertilization and culture (IVF group), blastocysts were collected and transferred to pseudo-pregnant recipient mice. Extraembryonic (ectoplacental cone and extraembryonic ectoderm) and placental tissues from both groups were sampled at embryonic day (E) 7.5 (IVO, n = 822; IVF, n = 795) and E10.5 (IVO, n = 324; IVF, n = 278), respectively. The collected extraembryonic (E7.5) and placental tissues (E10.5) were then used for high-throughput RNA sequencing (RNA-seq) and methylated DNA immunoprecipitation sequencing (MeDIP-seq). The main dysfunctions indicated by bioinformatic analyses were further validated using molecular detection, and morphometric and phenotypic analyses.
Dynamic functional profiling of high-throughput data, together with molecular detection, and morphometric and phenotypic analyses, showed that differentially expressed genes dysregulated by DNA methylation were functionally involved in: (i) actin cytoskeleton disorganization in IVF extraembryonic tissues, which may impair allantois or chorion formation, and chorioallantoic fusion; (ii) disturbed hematopoiesis and vasculogenesis, which may lead to abnormal placenta labyrinth formation and thereby impairing nutrition transport in IVF placentas; (iii) dysregulated energy and amino acid metabolism, which may cause placental dysfunctions, leading to delayed embryonic development or even lethality; (iv) disrupted genetic information processing, which can further influence gene transcriptional and translational processes.
LIMITATIONS, REASONS FOR CAUTION: Findings in mouse placental tissues may not be fully representative of human placentas. Further studies are necessary to confirm these findings and determine their clinical significance.
Our study is the first to provide the genome-wide analysis of gene expression dysregulation caused by DNA methylation during IVF placentation. Systematic understanding of the molecular mechanisms implicated in IVF placentation can be useful for the improvement of existing assisted conception systems to prevent these IVF-associated safety concerns.
This work was supported by grants from the National Natural Science Foundation of China (No. 31472092), and the National High-Tech R&D Program (Nos. 2011|AA100303, 2013AA102506). There was no conflict of interest.
体外受精(IVF)如何改变启动子DNA甲基化模式及其对小鼠胎盘形成过程中基因表达谱的后续影响?
IVF诱导的启动子DNA甲基化改变可能在IVF胎盘形成过程中的许多生物学过程和功能中产生功能性后果,包括肌动蛋白细胞骨架组织、造血作用、血管生成、能量代谢和营养物质运输。
在植入后胚胎发育过程中,胚胎组织和胚外组织都会经历DNA从头甲基化,从而建立整体DNA甲基化模式,并影响基因表达谱。IVF受孕胚胎的胚胎组织和胎盘组织可能具有异常的形态和功能,导致不良妊娠结局,如流产、低出生体重以及长期健康影响。迄今为止,尚未对IVF诱导的DNA甲基化改变的整体概况及其对IVF胎盘异常基因表达谱的功能后果进行系统研究。
研究设计、样本/材料、方法:使用癌症研究所小鼠(6周龄雌性和8 - 9周龄雄性)生成体内受精(IVO)和IVF囊胚。在进行IVO并发育(IVO组作为对照)或体外受精并培养(IVF组)后,收集囊胚并移植到假孕受体小鼠体内。分别在胚胎第(E)7.5天(IVO,n = 822;IVF,n = 795)和E10.5天(IVO,n = 324;IVF,n = 278)采集两组的胚外组织(外胎盘锥和胚外外胚层)和胎盘组织。然后将收集到的胚外组织(E7.5)和胎盘组织(E10.5)用于高通量RNA测序(RNA-seq)和甲基化DNA免疫沉淀测序(MeDIP-seq)。通过分子检测、形态计量学和表型分析进一步验证生物信息学分析指出的主要功能障碍。
高通量数据的动态功能分析,以及分子检测、形态计量学和表型分析表明,因DNA甲基化而失调的差异表达基因在功能上涉及:(i)IVF胚外组织中的肌动蛋白细胞骨架紊乱,这可能损害尿囊或绒毛膜形成以及绒毛膜尿囊融合;(ii)造血作用和血管生成受干扰,这可能导致胎盘迷路形成异常,从而损害IVF胎盘的营养物质运输;(iii)能量和氨基酸代谢失调,这可能导致胎盘功能障碍,导致胚胎发育延迟甚至死亡;(iv)遗传信息处理中断,这可能进一步影响基因转录和翻译过程。
局限性、注意事项:小鼠胎盘组织中的发现可能无法完全代表人类胎盘。需要进一步研究以证实这些发现并确定其临床意义。
我们的研究首次提供了IVF胎盘形成过程中由DNA甲基化引起的基因表达失调的全基因组分析。系统了解IVF胎盘形成所涉及的分子机制有助于改进现有的辅助受孕系统,以预防这些与IVF相关的安全问题。
本研究得到了中国国家自然科学基金(项目编号:31472092)以及国家高技术研究发展计划(项目编号:2011AA100303、2013AA102506)的资助。不存在利益冲突。